Hsbc Holdings PLC Coherus Bio Sciences, Inc. Transaction History

Hsbc Holdings PLC

$176 Billion
Q3 2025

A detailed history of Hsbc Holdings PLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 91,999 shares of CHRS stock, worth $109,478. This represents 0.0% of its overall portfolio holdings.

Number of Shares

91,999

Previous 102,296 10.07%

Holding current value

$109,478

Previous $74,000 102.7%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$0.75 - $1.7 $7,722 - $17,504	-10,297 Reduced 10.07%	91,999 $150,000
Q2 2025 Aug 13, 2025	SELL	$0.72 - $1.12 $1,937 - $3,013	-2,691 Reduced 2.56%	102,296 $74,000
Q1 2025 May 14, 2025	BUY	$0.81 - $1.66 $37 - $76	46 Added 0.04%	104,987 $85,000
Q4 2024 Feb 14, 2025	BUY	$0.67 - $1.71 $2,535 - $6,472	3,785 Added 3.74%	104,941 $144,000
Q3 2024 Nov 14, 2024	SELL	$0.99 - $1.8 $2,006 - $3,648	-2,027 Reduced 1.96%	101,156 $105,000

Q2 2024 Aug 12, 2024	BUY	$1.58 - $2.51 $15,649 - $24,861	9,905 Added 10.62%	103,183 $178,000
Q1 2024 May 15, 2024	SELL	$2.02 - $3.14 $13,303 - $20,680	-6,586 Reduced 6.59%	93,278 $222,000
Q4 2023 Feb 12, 2024	BUY	$1.59 - $3.85 $26,290 - $63,659	16,535 Added 19.84%	99,864 $332,000
Q3 2023 Nov 13, 2023	BUY	$3.74 - $5.45 $148,362 - $216,196	39,669 Added 90.86%	83,329 $311,000
Q2 2023 Aug 11, 2023	SELL	$3.79 - $8.3 $11,006 - $24,103	-2,904 Reduced 6.24%	43,660 $186,000
Q1 2023 May 15, 2023	BUY	$5.89 - $10.52 $8,652 - $15,453	1,469 Added 3.26%	46,564 $318,000
Q4 2022 Feb 14, 2023	BUY	$5.69 - $10.07 $178,318 - $315,583	31,339 Added 227.82%	45,095 $357,000
Q3 2022 Nov 14, 2022	SELL	$7.17 - $13.87 $255,266 - $493,799	-35,602 Reduced 72.13%	13,756 $137,000
Q2 2022 Aug 11, 2022	BUY	$5.86 - $13.23 $89,101 - $201,162	15,205 Added 44.52%	49,358 $363,000
Q1 2022 May 16, 2022	BUY	$10.92 - $16.41 $372,950 - $560,450	34,153 New	34,153 $449,000
Q3 2021 Nov 12, 2021	SELL	$12.68 - $17.79 $133,850 - $187,791	-10,556 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$12.95 - $15.41 $136,700 - $162,667	10,556 New	10,556 $145,000
Q1 2021 May 14, 2021	SELL	$14.42 - $21.39 $222,731 - $330,389	-15,446 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$16.56 - $18.94 $255,785 - $292,547	15,446 New	15,446 $268,000
Q3 2020 Nov 12, 2020	SELL	$17.41 - $19.89 $224,084 - $256,004	-12,871 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$14.43 - $19.16 $47,416 - $62,959	-3,286 Reduced 20.34%	12,871 $230,000
Q1 2020 May 15, 2020	BUY	$11.67 - $22.53 $70,533 - $136,171	6,044 Added 59.76%	16,157 $259,000
Q4 2019 Feb 14, 2020	SELL	$16.33 - $21.37 $106,994 - $140,016	-6,552 Reduced 39.32%	10,113 $182,000
Q3 2019 Nov 14, 2019	BUY	$16.3 - $23.37 $271,639 - $389,461	16,665 New	16,665 $338,000

Others Institutions Holding CHRS

# of Institutions

125

Shares Held

54.7M

Call Options Held

291K

Put Options Held

120K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $92.5M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Coherus Bio Sciences, Inc. Transaction History